Diisopropylethylamine → (2-chloromethyl-pyridin-4-yl)-[2-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-4,5,7,8-tetrahydro-1H-imidazo[4,5-d]azepin-6-yl]-methanone
反応式
Cl.[CH3:2][O:3][C:4]1[C:9]2[N:10]=[C:11]([C:13]3[NH:22][C:16]4[CH2:17][CH2:18][NH:19][CH2:20][CH2:21][C:15]=4[N:14]=3)[S:12][C:8]=2[C:7]([N:23]2[CH2:28][CH2:27][O:26][CH2:25][CH2:24]2)=[CH:6][CH:5]=1.C(N(C(C)C)C(C)C)C.Cl.[Cl:39][CH2:40][C:41]1[CH:42]=[C:43]([CH:47]=[CH:48][N:49]=1)[C:44](Cl)=[O:45]>O1CCCC1>[Cl:39][CH2:40][C:41]1[CH:42]=[C:43]([C:44]([N:19]2[CH2:20][CH2:21][C:15]3[N:14]=[C:13]([C:11]4[S:12][C:8]5[C:7]([N:23]6[CH2:24][CH2:25][O:26][CH2:27][CH2:28]6)=[CH:6][CH:5]=[C:4]([O:3][CH3:2])[C:9]=5[N:10]=4)[NH:22][C:16]=3[CH2:17][CH2:18]2)=[O:45])[CH:47]=[CH:48][N:49]=1参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
To a suspension of 0.04 g 2-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-1,4,5,6,7,8-hexahydro-imidazo[4,5-d]azepine hydrochloride in 3.4 ml tetrahydrofurane were added at 0–4° C. 0.09 ml N-ethyldiisopropylamine and 0.017 g 2-chloromethyl-isonicotinoyl chloride hydrochloride. The mixture was refluxed for 17 hours, silicagel was added and the solvent was distilled off. The residue was transferred to a column prefilled with silicagel and was chromatographed with dichloromethane/methanol 96:4 to yield 0.037 g (68%) (2-chloromethyl-pyridin-4-yl)-[2-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-4,5,7,8-tetrahydro-1H-imidazo[4,5-d]azepin-6-yl]-methanone as yellow solid; MS (ISP): m/e=540 (M+H+).
後処理
- additionwere added at 0–4° C
- temperatureThe mixture was refluxed for 17 hours
- additionsilicagel was added
- distillationthe solvent was distilled off
- customwas chromatographed with dichloromethane/methanol 96:4
出典と根拠
- ORDレコード
- ord-54b0464ff01b4da5bbdc14e2c967da85
- 出典データセット
- uspto-grants-2006_10
- 特許番号
- US07122545B2
反応ノート
読み込み中…